These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12823595)

  • 1. Predicting progression to cirrhosis in chronic hepatitis C virus infection.
    Freeman AJ; Law MG; Kaldor JM; Dore GJ
    J Viral Hepat; 2003 Jul; 10(4):285-93. PubMed ID: 12823595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of metabolic syndrome in the setting of chronic hepatitis C virus infection.
    Hanouneh IA; Feldstein AE; Lopez R; Yerian L; Pillai A; Zein CO; Zein NN
    Clin Gastroenterol Hepatol; 2008 May; 6(5):584-9. PubMed ID: 18455698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variation in the interleukin-28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection.
    Marabita F; Aghemo A; De Nicola S; Rumi MG; Cheroni C; Scavelli R; Crimi M; Soffredini R; Abrignani S; De Francesco R; Colombo M
    Hepatology; 2011 Oct; 54(4):1127-34. PubMed ID: 21721028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SEN virus infection influences the pathological findings in liver but does not affect the incidence of hepatocellular carcinoma in patients with chronic hepatitis C and liver cirrhosis.
    Moriyama M; Mikuni M; Matsumura H; Nakamura H; Oshiro S; Aoki H; Shimizu T; Yamagami H; Shioda A; Kaneko M; Tanaka N; Arakawa Y
    Liver Int; 2005 Apr; 25(2):226-35. PubMed ID: 15780043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus risk factors in the Turkish community.
    Yildirim B; Tahan V; Ozaras R; Aytekin H; Mert A; Tabak F; Senturk H
    Dig Dis Sci; 2005 Dec; 50(12):2352-5. PubMed ID: 16416188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of viral load and genotype in the progression of Hepatitis B-associated liver cirrhosis to hepatocellular carcinoma.
    Mahmood S; Niiyama G; Kamei A; Izumi A; Nakata K; Ikeda H; Suehiro M; Kawanaka M; Togawa K; Yamada G
    Liver Int; 2005 Apr; 25(2):220-5. PubMed ID: 15780042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.
    Leandro G; Mangia A; Hui J; Fabris P; Rubbia-Brandt L; Colloredo G; Adinolfi LE; Asselah T; Jonsson JR; Smedile A; Terrault N; Pazienza V; Giordani MT; Giostra E; Sonzogni A; Ruggiero G; Marcellin P; Powell EE; George J; Negro F;
    Gastroenterology; 2006 May; 130(6):1636-42. PubMed ID: 16697727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients.
    Pol S; Fontaine H; Carnot F; Zylberberg H; Berthelot P; Bréchot C; Nalpas B
    J Hepatol; 1998 Jul; 29(1):12-9. PubMed ID: 9696487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.
    Di Martino V; Rufat P; Boyer N; Renard P; Degos F; Martinot-Peignoux M; Matheron S; Le Moing V; Vachon F; Degott C; Valla D; Marcellin P
    Hepatology; 2001 Dec; 34(6):1193-9. PubMed ID: 11732009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronic hepatitis C virus infection and associated liver disease among the inmates of a Spanish prison].
    Murcia J; Portilla J; Bedia M; Palazón JM; Sánchez-Payá J; Saiz de la Hoya P; Payá A; Boix V; Merino E; Reus S
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):206-12. PubMed ID: 19246126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus: publication bias?
    Goodgame B; Shaheen NJ; Galanko J; El-Serag HB
    Am J Gastroenterol; 2003 Nov; 98(11):2535-42. PubMed ID: 14638360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration.
    Zampino R; Pisaturo MA; Cirillo G; Marrone A; Macera M; Rinaldi L; Stanzione M; Durante-Mangoni E; Gentile I; Sagnelli E; Signoriello G; Miraglia Del Giudice E; Adinolfi LE; Coppola N
    Ann Hepatol; 2015; 14(1):75-82. PubMed ID: 25536644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome.
    Sanyal AJ; Contos MJ; Sterling RK; Luketic VA; Shiffman ML; Stravitz RT; Mills AS
    Am J Gastroenterol; 2003 Sep; 98(9):2064-71. PubMed ID: 14499789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.
    Hissar SS; Kumar M; Tyagi P; Goyal A; Suneetha PV; Agarwal S; Rastogi A; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2009 Apr; 24(4):581-7. PubMed ID: 19032460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying the superior measure of rapid fibrosis for predicting premature cirrhosis after liver transplantation for hepatitis C.
    Howell J; Sawhney R; Angus P; Fink M; Jones R; Wang BZ; Visvanathan K; Crowley P; Gow P
    Transpl Infect Dis; 2013 Dec; 15(6):588-99. PubMed ID: 24028328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.
    Poynard T; Bedossa P; Opolon P
    Lancet; 1997 Mar; 349(9055):825-32. PubMed ID: 9121257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological features of chronic hepatitis C in haemodialysis patients.
    Sakellariou S; Boletis JN; Sypsa V; Psichogiou M; Tiniakos D; Delladetsima I
    Liver Int; 2014 Jul; 34(6):e56-61. PubMed ID: 25234282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rate of liver fibrosis progression among patients with chronic hepatitis C in Poland].
    Kryczka W; Chrapek M; Paluch K; Zarebska-Michaluk D; Urbaniak A
    Pol Arch Med Wewn; 2003 Aug; 110(2):869-75. PubMed ID: 14682226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver fibrosis progression in HIV/hepatitis C virus coinfected patients with normal aminotransferases levels.
    Pace FH; Ferreira LE; Silva AE; Ferraz ML
    Rev Soc Bras Med Trop; 2012; 45(4):444-7. PubMed ID: 22930041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.